{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:06:10Z","timestamp":1770505570002,"version":"3.49.0"},"reference-count":15,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1080\/00365540310008410","type":"journal-article","created":{"date-parts":[[2003,8,28]],"date-time":"2003-08-28T18:43:06Z","timestamp":1062096186000},"page":"299-301","source":"Crossref","is-referenced-by-count":2,"title":["Tetanus Antitoxin Seroprevalence in Patients with Beh\u00e7et's Disease"],"prefix":"10.1080","volume":"35","author":[{"given":"Ergin","family":"Ayaslioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emel","family":"Erkek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Kili\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Kaygusuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nursen","family":"D\u00fczg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","first-page":"128","volume":"24","author":"Turan B","year":"1997","journal-title":"Systemic levels of T cell regulatory cytokines IL-10 and IL-12 in Behcet\u2019s disease, soluble TNFR-75 as a biological marker of disease activity. J Rheumatol"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1468-3083.2001.00251.x","volume":"15","author":"\u00d6nder M","year":"2001","journal-title":"J Eur Acad Dermatol"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-2249.1997.d01-947.x","volume":"107","author":"Esin S","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"CIT0004","first-page":"321","volume":"23","author":"Sayinalp N","year":"1996","journal-title":"J Rheumatol"},{"key":"CIT0005","unstructured":"Jorizzo JL. Beh\u00e7et\u2019s disease. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, eds. Dermatology in general medicine, 5th edn. New York: McGraw-Hill; 2000. p. 2161\u20135."},{"key":"CIT0006","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","journal-title":"Lancet"},{"key":"CIT0007","first-page":"167","volume":"19","author":"Maple PAC","year":"2001","journal-title":"Immunity to diphtheria and tetanus in England and Wales. Vaccine"},{"key":"CIT0008","first-page":"1145","volume":"17","author":"Kr\u00fcger S","year":"1999","journal-title":"Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination. Vaccine"},{"key":"CIT0009","first-page":"350","volume":"38","author":"Sakane T","year":"1997","journal-title":"Nagafuchi H. Etiopathology of Beh\u00e7et\u2019s disease: immunological aspects. Yonsei Med J"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(02)08028-5","volume":"359","author":"Stark K","year":"2002","journal-title":"Lancet"},{"key":"CIT0011","first-page":"905","volume":"20","author":"Dieye TN","year":"2002","journal-title":"Immunologic and virologic response after tetanus toxoid booster among HIV-1 and HIV-2-infected Senegalese individuals. Vaccine"},{"key":"CIT0012","first-page":"282","volume":"205","author":"Mayer S","year":"2002","journal-title":"Krause SW. Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay. Immunology"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/003655401317074491","volume":"33","author":"Erg\u00f6nul E","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"CIT0014","first-page":"53","volume":"27","author":"Laroche P","year":"1999","journal-title":"The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV). Infection"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(97)80123-7","volume":"349","author":"Sehgal R","year":"1997","journal-title":"Lancet"}],"container-title":["Scandinavian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00365540310008410","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T20:10:09Z","timestamp":1497557409000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00365540310008410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1080\/00365540310008410"],"URL":"https:\/\/doi.org\/10.1080\/00365540310008410","relation":{},"ISSN":["0036-5548","1651-1980"],"issn-type":[{"value":"0036-5548","type":"print"},{"value":"1651-1980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}